10:00 to 10:20
Symposium

Targetable Leukemia Dependency on Noncanonical PI3Ky Signaling

Session 1

Andrew Lane
First International THEMA Leukemia Symposium
10:00 to 10:20
    Amphithéâtre Marguerite de Navarre, Site Marcelin Berthelot
    Open to all, subject to availability
    -

    Speaker(s)

    Andrew Lane

    Events

    Symposium
    09:00 to 09:30
    Hugues de Thé, Lise Alter & Matthieu Resche-Rigon

    Opening speech

    Not recorded
    Symposium
    09:30 to 09:50
    Andreas Trumpp

    Therapy Response and Resistance of AML Stem Cells to Venetoclax
    Symposium
    10:00 to 10:20
    Andrew Lane

    Targetable Leukemia Dependency on Noncanonical PI3Ky Signaling
    Symposium
    10:30 to 10:50
    Alexandre Puissant

    Overcoming Therapy Resistance in Acute Myeloid Leukemia
    Symposium
    11:10 to 11:40
    Nina Cabezas

    Regulation of Hematopoietic Stem Cell Dormancy
    Symposium
    11:40 to 12:00
    Lina Benajiba

    Unmasking Myeloproliferative Neoplasms Transformation Paths
    Symposium
    12:05 to 12:30
    Clemens Schmitt

    AML State-Switched

    Not recorded
    Symposium
    14:30 to 14:55
    Marc Raaijmakers

    Deconstructing Niche Contributions to Disease Pathogenesis and Drug Resistance in AML

    Symposium
    14:55 to 15:20
    Diana Passaro

    Unveil the Role of the Bone Marrow Vascular Niche in Acute Leukemia

    Not recorded
    Symposium
    15:20 to 15:40
    David Michonneau

    Lessons from Azithromycin after allo-HSCT: how an antibiotic can promote relapse by disrupting immun…
    Symposium
    16:00 to 16:20
    Emmanuel Raffoux

    Quality of Life Matters: A patient perspective
    Symposium
    16:20 to 16:45
    Courtney DiNardo

    AML Therapy in 2024: increasingly individualized approaches
    Symposium
    16:45 to 17:05
    Olivier Kosmider

    VEXAS Syndrome in 2024
    Symposium
    17:05 to 17:30
    Régis Peffault de Latour

    Paroxysmal Nocturnal Hemoglobinuria as an Original Non-Malignant Clonal Expansion Modulated by Compl…
    Symposium
    09:00 to 09:25
    Lars Velten

    Tracking Human Hematopoietic Stem Cell Clones in Health and Disease
    Symposium
    09:25 to 09:50
    Emmanuelle Clappier

    Genomic and Clinical Heterogeneity within Adult Acute Lymphoblastic Leukemia
    Symposium
    09:50 to 10:15
    Guillaume Andrieu

    From Metabolic Vulnerabilities to Targeted Therapies in Leukemia
    Symposium
    10:15 to 10:40
    Anindita Roy

    Developmental Origins of Childhood Leukemia: why does it matter?
    Symposium
    11:00 to 11:25
    Timothy Ley

    AML: Lessons from the Genome

    Not recorded
    Symposium
    11:25 to 11:50
    Ruud Delwel

    Targeting Evil Enhancers and Genes in AML
    Symposium
    11:50 to 12:20
    Raphael Itzykson

    Targeting Cystine Import in AML
    Symposium
    13:50 to 14:15
    Keisuke Ito

    Mitochondrial Contributions to Hematopoietic Homeostasis and the Pathogenesis of Hematological Disor…
    Symposium
    14:15 to 14:40
    Bethan Psaila

    Targeting Microenvironmental Drivers of Blood Malignancies

    Not recorded
    Symposium
    14:40 to 15:10
    Lionel Adès

    Any Crosstalk in the Treatment of AML and HR-MDS
    Symposium
    15:30 to 15:50
    Marie Sebert

    Clonal Evolution of Genetic Predisposition to Hematological Malignancies
    Symposium
    15:50 to 16:15
    Domitille Rérolle

    PML Unravels New Insights into the Bases of AML Chemotherapy Response
    Symposium
    16:15 to 16:40
    Paresh Vyas

    Clonal Haemopoiesis: stem cell dynamics and stem cell response to inflammation

    See also

    Hugues de Thé, chair Cellular and Molecular Oncology
    First International THEMA Leukemia Symposium